Squarepoint
WST icon

Squarepoint’s West Pharmaceutical WST Stock Holding History

Squarepoint’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,200
Closed -$775K – 4679
2023
Q4 		$775K Sell
2,200
-13,100
-86% -$4.64M ﹤0.01% 2709
2023
Q3 		$5.74M Buy
+15,300
New +$5.92M 0.01% 1083

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Squarepoint's WST Position: Q1 2026 in Review

Squarepoint increased its West Pharmaceutical (WST) stake by 7.5% in Q1 2026, buying an estimated $409K and bringing the position to 23,661 shares worth $5.93M. The position accounts for 0.01% of the portfolio, ranked #1375.

Squarepoint first reported a position in WST in Q2 2016 and has held it in 34 quarters since. The position peaked at $37.7M in Q4 2023. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Squarepoint held 23,661 shares of West Pharmaceutical worth $5.93M as of Q1 2026.
  • Squarepoint bought 1,642 West Pharmaceutical shares in Q1 2026, an estimated $409K.
  • West Pharmaceutical made up 0.01% of Squarepoint's portfolio in Q1 2026, its #1375 holding.
  • Squarepoint first reported a position in West Pharmaceutical in Q2 2016 and has held it in 34 quarters since.
  • Squarepoint's West Pharmaceutical position peaked at $37.7M in Q4 2023.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.